Julie Andrews
CIK 1550508 · CFO · last filed 2026-06-18
Julie Andrews is a CFO who has filed 38 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for RXST, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions. 20 SEC filings were submitted jointly with Wright Medical Group N.V.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RXST price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ARLINGTON, TN 38002
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RXST | Director | 78,076 | $4.86 | $379.4K | -$656.3K | 7 | 2026-06-18 |
| OFIX | CFO | 88,746 | $7.90 | $701.1K | -$214.3K | 6 | 2026-03-06 |
| Wright Medical Group N.V. (WMGI) Delisted | SVP, Global Finance | 50,038 | — | — | -$397.2K | 8 | 2020-08-19 |
| Wright Medical Group N.V. (WMGIZ) Delisted | VP, Finance and CAO | 30,923 | — | — | -$85.7K | 5 | 2018-08-20 |
| Wright Medical Group N.V. (WMGI.Z) Delisted | VP & Chief Accounting Officer | 26,649 | — | — | -$109.2K | 9 | 2016-07-21 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-18 | RXST | Grant (A) | +37,037 | $0 | EDGAR |
| 2026-03-06 | OFIX | Sell (S) | −4,788 | -$61.0K | EDGAR |
| 2026-03-05 | OFIX | Grant (A) | +35,495 | $0 | EDGAR |
| 2026-01-21 | OFIX | Sell (S) | −4,873 | -$70.1K | EDGAR |
| 2025-06-04 | RXST | Grant (A) | +10,752 | $0 | EDGAR |
| 2025-03-05 | OFIX | Grant (A) | +34,600 | $0 | EDGAR |
| 2025-01-21 | OFIX | Sell (S) | −4,655 | -$83.3K | EDGAR |
| 2024-06-17 | RXST | Sell (S) | −15,625 | -$906.3K | EDGAR |
| 2024-06-14 | RXST | Notice (144) | −15,625 | -$922.3K | EDGAR |
| 2024-06-10 | RXST | Grant (A) | +2,554 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.